2013
DOI: 10.1111/dme.12150
|View full text |Cite
|
Sign up to set email alerts
|

Influence of peripheral arterial occlusive disease on the Neuropad® test performance in patients with diabetes

Abstract: The reliability of the Neuropad is not significantly different in the presence or absence of peripheral arterial occlusive disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
(72 reference statements)
1
0
0
Order By: Relevance
“…At this time, the test better discriminated patients between groups 2 and 3 (1/7 vs. 5/7 patients with grade 0, respectively) but was not accurate to provide an early marker of neuropathy in asymptomatic carriers who all showed an intermediate grade 1 corresponding to partial sweating. This gain in sensitivity but loss in specificity at a shorter time of assessment was reported previously . The initial technique of the Neuropad test was to measure the time required for complete color change, i.e.…”
Section: Discussionsupporting
confidence: 59%
“…At this time, the test better discriminated patients between groups 2 and 3 (1/7 vs. 5/7 patients with grade 0, respectively) but was not accurate to provide an early marker of neuropathy in asymptomatic carriers who all showed an intermediate grade 1 corresponding to partial sweating. This gain in sensitivity but loss in specificity at a shorter time of assessment was reported previously . The initial technique of the Neuropad test was to measure the time required for complete color change, i.e.…”
Section: Discussionsupporting
confidence: 59%